Design
This was a parallel 2-arm individually randomized clinical trial of patients from 9 primary care sites in Ontario, Canada. After initiation of the trial that was originally planned to last 12 months for each participant, additional funding was obtained to extend the intervention to 36 months, but primary data collection from the control group ended after 24 months.